Work

Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study).

Year: 2010

Type: article

Source: PubMed

Authors: Wu Zhang, Mizutomo Azuma, Georg Lurje, Michael A Gordon, Dongyun Yang, Alexandra Pohl, Yan Ning, Pierre Bohanes, Armin Gerger, Thomas Winder, Ellen Hollywood, Kathleen D Danenberg, Leonard Saltz, Heinz-Josef Lenz

Institution: USC Norris Comprehensive Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)

OpenAlex ID: W2109561752

FWCI: 1.622

Cites: 27

Cited by: 39

Related to: 10